Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a type of medication used to treat type 2 diabetes. It was developed and is marketed by Novo Nordisk, a Danish pharmaceutical company. GLP-1 is a hormone that is naturally produced in the gut in response to food intake. It promotes insulin secretion and reduces glucagon secretion, …